专利名称：(HET)ARYL-P-QUINONE DERIVATIVES FOR
TREATMENT OF MITOCHONDRIAL DISEASES
发明人：Andrew W. HIinman,Kieron E. Wesson申请号：US12811694申请日：20090106
公开号：US20110046219A1公开日：20110224
摘要：Methods of treating or suppressing mitochondrial diseases, such as Friedreich'sataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), mitochondrial myopathy,encephalopathy, lactacidosis, stroke (MELAS), Kearns-Sayre Syndrome (KSS), aredisclosed, as well as compounds useful in the methods of the invention, such as 2-(3-hydroxy-3-methyl-butyl)-6-(het)aryl-p-quinone or as 2-(3-hydroxy-3-methylbutyl)-3-(het)aryl-p-quinone derivatives. Energy biomarkers useful in assessing the metabolicstate of a subject and the efficacy of treatment are also disclosed. Methods of
modulating, normalizing, or enhancing energy biomarkers, as well as compounds usefulfor such methods, are also disclosed.
申请人：Andrew W. HIinman,Kieron E. Wesson
地址：San Francisco CA US,Burlingame CA US
国籍：US,US
更多信息请下载全文后查看
因篇幅问题不能全部显示，请点此查看更多更全内容